Procter & Gamble SEC Filings

Christopher J. Kempczinski, a director of Procter & Gamble Co (PG), was awarded 197 Restricted Stock Units (RSUs) on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a price of $0 and the reported total beneficial ownership after the award is 9,166.4401 common shares, which includes dividend equivalents credited as additional RSUs. The filing reports the grant as a non‑derivative equity award and identifies the award as restricted stock units and dividend equivalents; no options, sales, or cash transactions are disclosed.

Craig Arnold, a director of Procter & Gamble Co. (PG), was granted 189 restricted stock units (RSUs) on 09/09/2025. The award is under The Procter & Gamble 2019 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional RSUs. The filing reports 703.4862 shares (or RSU-equivalent) beneficially owned by the reporting person after the transaction. The Form 4 was signed by an attorney-in-fact on 09/10/2025 and discloses this non-derivative equity award.

Robert J. Portman, a director of Procter & Gamble Co. (PG), was granted 48 Restricted Stock Units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were recorded at a price of $0 and the reporting shows 3,419.5944 shares beneficially owned after the grant, a total that the filing states includes dividend equivalents credited as RSUs. The Form 4 was filed as a single-person filing and signed by an attorney-in-fact on 09/10/2025. The document contains only the listed grant details and explanatory footnotes.

Ashley McEvoy, a director of Procter & Gamble Co (PG), was awarded 189 shares of Common Stock on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The grant carries a $0 per-share transaction price and the total post-transaction beneficial ownership is reported as 3,843.0241 shares, which the filer says includes dividend equivalents issued as Restricted Stock Units. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The filing discloses a routine equity award to a director as part of compensation; no sale or cash purchase occurred.

Christine M. McCarthy, a director of Procter & Gamble Co. (PG), reports a grant of 236 Restricted Stock Units (RSUs) on 09/09/2025 under the Procter & Gamble 2019 Stock & Incentive Compensation Plan. The RSUs were granted with a reported price of $0 and include dividend equivalents converted into additional RSUs. Following the grant, Ms. McCarthy beneficially owns 14,946.5131 shares (reported as direct ownership). The filing is signed by an attorney-in-fact on 09/10/2025 and includes the plan-based award disclosure in the explanatory notes.

Terry J. Lundgren, a director of Procter & Gamble (PG), was awarded 220 restricted stock units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a $0 per-share price as dividend-equivalent RSUs and are reported as 220 units added to his holdings. Following the transaction, Mr. Lundgren beneficially owns a total of 43,397.6912 shares, which includes RSU dividend equivalents and shares from the issuer's dividend reinvestment plan. Additionally, 530 shares are reported as indirectly held by his spouse.

Joseph Jimenez, a director of Procter & Gamble Co. (PG), was granted 298 restricted stock units (RSUs) on 09/09/2025. The award is reported as having a $0 per-share price because it is a restricted grant rather than an open-market purchase. After the grant (which includes dividend equivalents credited as RSUs), Mr. Jimenez beneficially owns 34,100.9784 shares in total. The RSUs were awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Jimenez on 09/10/2025.

The Vanguard Group reported ownership of 235,208,844 shares of Procter & Gamble (PG), representing 10.04% of the outstanding common stock. Vanguard discloses it is an investment adviser (IA) organized in Pennsylvania and holds 0 sole voting power, 13,404,221 shares with shared voting power, 212,819,403 shares with sole dispositive power, and 22,389,441 shares with shared dispositive power. The filing is a Schedule 13G/A amendment dated August 29, 2025, signed September 8, 2025.

Vanguard states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Procter & Gamble; the filing lists client accounts as the ultimate beneficial owners where applicable.

Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble (PG), reported a sale of 1,000 shares of P&G common stock on 08/29/2025 at $156.835 per share. After the sale she beneficially owned 28,435.8354 shares directly and 6,477.4515 shares indirectly via a retirement plan trustee. The Form 4 was executed by an attorney-in-fact.